CompoAtlas

UBAT CAP TOONG YIN THONG (SERBUK)

UBAT CAP TOONG YIN THONG (SERBUK) : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
SEMEN ARECA CATECHUSEMEN ARECA CATECHU[233MG]Not identified
Rhizoma corydalis yanhusuoRhizoma corydalis yanhusuo[350MG]Not identified
RAPHANUS SATIVUS SEMENRAPHANUS SATIVUS SEMEN[233MG ]Not identified
PERILLA FRUTESCENS FOLIUMPERILLA FRUTESCENS FOLIUM[250MG ]Not identified
INULA HELENIUM RADIXINULA HELENIUM RADIX[116MG ]Not identified
HERBA ARTEMISIAE CAPILLARISHERBA ARTEMISIAE CAPILLARIS[320MG ]Not identified
HERBA AGASTACHE RUGOSAHERBA AGASTACHE RUGOSA[320MG ]Not identified
GLYCYRHIZA GLABRA RADIXGLYCYRHIZA GLABRA RADIX[233MG ]Not identified
CYPERUS ROTUNDUS RHIZOMECYPERUS ROTUNDUS RHIZOME[250MG ]Not identified
CITRUS NOBILIS PERICARPIUMCITRUS NOBILIS PERICARPIUM[116MG ]Not identified
ATRACTYLIS OVATA RHIZOMAATRACTYLIS OVATA RHIZOMA[233MG ]Not identified
ANGELICAE DAHURICAE RADIXANGELICAE DAHURICAE RADIX[150MG ]Not identified
AMOMUM VILLOSUM LOUR FRUCTUSAMOMUM VILLOSUM LOUR FRUCTUS[161MG ]Not identified
ALISMA PLANTAGO AQUATICAALISMA PLANTAGO AQUATICA[350MG ]Not identified
HERBA MENTHA HAPLOCALYXHERBA MENTHA HAPLOCALYX[385MG]Not identified
Rhizoma atractylodes macrocephalaRhizoma atractylodes macrocephala[300MG]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL20032344T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
TJ-TYT PHARMACEUTICALS (M) SDN. BHD.
Manufacturer
TJ-TYT PHARMACEUTICALS (M) SDN. BHD.
Registration period starting
2023-04-06
Published validity end
2028-04-06

Original register data

View published fields and their variants
Active ingredients
SEMEN ARECA CATECHU[233MG],Rhizoma corydalis yanhusuo[350MG],RAPHANUS SATIVUS SEMEN[233MG ],PERILLA FRUTESCENS FOLIUM[250MG ],INULA HELENIUM RADIX[116MG ],HERBA ARTEMISIAE CAPILLARIS[320MG ],HERBA AGASTACHE RUGOSA[320MG ],GLYCYRHIZA GLABRA RADIX[233MG ],CYPERUS ROTUNDUS RHIZOME[250MG ],CITRUS NOBILIS PERICARPIUM[116MG ],ATRACTYLIS OVATA RHIZOMA[233MG ],ANGELICAE DAHURICAE RADIX[150MG ],AMOMUM VILLOSUM LOUR FRUCTUS[161MG ],ALISMA PLANTAGO AQUATICA[350MG ],HERBA MENTHA HAPLOCALYX[385MG],Rhizoma atractylodes macrocephala[300MG]
Valid until
2028-04-06
Registration date
2023-04-06
Published description
NATURAL PRODUCT
Licence holder
TJ-TYT PHARMACEUTICALS (M) SDN. BHD.
Producer
TJ-TYT PHARMACEUTICALS (M) SDN. BHD.
Published name
UBAT CAP TOONG YIN THONG (SERBUK)
Published reference
2001127419T
Registration number
MAL20032344T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL20032344T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “UBAT CAP TOONG YIN THONG (SERBUK)”, https://compoatlas.com/en/supplements/malaysia/MAL20032344T-ubat-cap-toong-yin-thong-serbuk, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line